Nom du produit:3-(3-(5-methyl-1H-imidazol-1-yl)propyl)-2-thioxo-2,3-dihydroquinazolin-4(1H)-one
IUPAC Name:3-[3-(5-methyl-1H-imidazol-1-yl)propyl]-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-4-one
- CAS:1072441-36-1
- Formule moléculaire:C15H16N4OS
- Pureté:95%+
- Numéro de catalogue:CM1048392
- Poids moléculaire:300.38
Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1072441-36-1
- Formule moléculaire:C15H16N4OS
- Point de fusion:-
- Code SMILES:O=C1N(CCCN2C(C)=CN=C2)C(NC3=C1C=CC=C3)=S
- Densité:
- Numéro de catalogue:CM1048392
- Poids moléculaire:300.38
- Point d'ébullition:535.2±52.0 °C at 760 mmHg
- N° Mdl:
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.